BioTime Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
43,882.80
36,324.80
46,991.00
33,572.00
19,976.00
45,990
Depreciation, Depletion & Amortization
3,952.50
8,410.30
6,334.00
4,757.00
3,296.00
3,273
Other Funds
-
-
3,789.00
567.00
153.00
11,197
Funds from Operations
32,307.20
38,027.20
47,849.00
41,585.00
32,995.00
31,520
Changes in Working Capital
2,798.60
827.10
3,305.00
741.00
2,478.00
638
Net Operating Cash Flow
29,508.60
38,854.20
44,544.00
42,326.00
30,517.00
30,882
Capital Expenditures
2,277.20
483.10
5,334.00
2,526.00
1,326.00
Sale of Fixed Assets & Businesses
30.90
9.20
-
-
200.00
Purchase/Sale of Investments
-
-
2,107.00
13.00
201.00
Net Investing Cash Flow
3,665.60
1,007.80
7,441.00
10,889.00
10,225.00
Issuance/Reduction of Debt, Net
-
444.60
196.00
1,612.00
172.00
Net Financing Cash Flow
34,263.60
63,623.20
64,775.00
32,782.00
55,391.00
Net Change in Cash
1,145.50
23,991.40
12,742.00
20,141.00
14,750.00
Free Cash Flow
31,785.80
39,337.30
49,878.00
44,852.00
31,843.00
Deferred Taxes & Investment Tax Credit
3,280.70
7,375.60
4,516.00
-
-
-
Net Assets from Acquisitions
978.10
-
-
-
-
Change in Capital Stock
34,263.60
63,178.60
60,790.00
30,603.00
55,066.00
Exchange Rate Effect
56.10
230.20
48.00
292.00
101.00
Other Uses
441.20
533.90
-
8,376.00
8,898.00
About BioTime
View Profile
